A randomized, double-masked, placebo-controlled two cross-over study comparing the effects of moxaverine and placebo on ocular blood flow
- Conditions
- healthy persons
- Registration Number
- EUCTR2006-001783-23-AT
- Lead Sponsor
- RSAPHARM Arzneimittel GmbH & Co. KG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
healthy persons
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Symptoms of any systemic disease, abuse of medications, beverages or drugs
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Effect of moxaverine in comparison to placebo on ocular blood flow;Secondary Objective: no;Primary end point(s): Retinal, choroidal and optic nerve head blood flow
- Secondary Outcome Measures
Name Time Method